serious events including acute pancreatitis, acute kidney injury, and worsening diabetic retinopathy require prompt medical attention
Most people have only mild effects, especially when starting treatment
Tirzepatide isnt contraindicated in AF
These medications have been shown to be beneficial in treating Type 2 diabetes, and several medications in this class have also been permitted for chronic weight management as well as cardiovascular risk reduction
These included CT-996, a once-daily oral small-molecule oral GLP-1 receptor agonist, in Phase I, for treating obesity in patients with and without Type 2 diabetes, as well as two injectable clinical drug candidates: CT-388, a once-weekly subcutaneous injectable in Phase II, for treating obesity in patients with and without Type 2 diabetes, and CT-868, a once-daily subcutaneous injectable, in Phase II, for treating Type 1 diabetes patients with overweight or obesity
I keep my vials, syringes, and a bag of alcohol pads neatly organized, making the process quick and hygienic